cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Atai Life Sciences Nv
18 own
22 watching
Current Price
$1.4
$0.06
(4.48%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
217.68M
52-Week High
52-Week High
2.85000
52-Week Low
52-Week Low
0.78000
Average Volume
Average Volume
1.79M
Dividend Yield
Dividend Yield
0.41
P/E Ratio
P/E Ratio
20.43
iconMarket Capitalization217.68M
icon52-Week High2.85000
icon52-Week Low0.78000
iconAverage Volume1.79M
iconDividend Yield0.41
iconP/E Ratio20.43
What does the Atai Life Sciences Nv do?
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company s therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder; RLS-01, a formulation of Salvinorin A for TRD; KUR-101, an oral formulation of deuterated mitragynine to treat OUD; and DMX-1001, an oral formulation of noribogaine for the treatment of OUD. The company was formerly known as Adripa Holding B.V. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.
Read More
How much money does Atai Life Sciences Nv make?
News & Events about Atai Life Sciences Nv.
Globe Newswire
1 year ago
- Pharmacodynamic profile of GRX-917 indicates potential for anxiolytic activity without the significant sedative side effects associated with benzodiazepines NEW YORK and BERLIN, April 28, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences(NASDAQ: ATAI) (atai), a clinical-stage biopharmaceutical company ...
Globe Newswire
1 year ago
atais development candidates, such as RL-007 and GRX-917, all represent significant opportunities to address unmet medical needs of patients living with mental health conditionsContinued operational progress on robust clinical pipeline, with multiple phase 1 and phase 2 proof-of-concept datasets ...
Globe Newswire
1 year ago
NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (atai or the Company), a clinical-stage biopharmaceutical company focused on mental health, announced that, while PCN-101 (R-ketamine) demonstrated signals of efficacy across all timepoints out to two weeks, ...
Globe Newswire
1 year ago
- This two-part phase 1 trial in healthy volunteers was designed to assess the safety, pharmacokinetics, and analgesic activity of KUR-101 - KUR-101 was well tolerated and demonstrated analgesic activity in two experimental pain models - An assessment of the respiratory impact of KUR-101 was ...
Globe Newswire
1 year ago
NEW YORK and BERLIN, Dec. 16, 2022 (GLOBE NEWSWIRE) -- atai Impact, the philanthropic arm of atai Life Sciences N.V. (NASDAQ: ATAI) (atai), today announced the first cohort of the atai Fellowship Fund in Psychedelic Neuroscience (the Fellowship Fund) at Massachusetts General Hospital (MGH) Center ...
Frequently Asked Questions
Frequently Asked Questions
What is Atai Life Sciences Nv share price today?
plus_minus_icon
Can Indians buy Atai Life Sciences Nv shares?
plus_minus_icon
How can I buy Atai Life Sciences Nv shares from India?
plus_minus_icon
Can Fractional shares of Atai Life Sciences Nv be purchased?
plus_minus_icon
What are the documents required to start investing in Atai Life Sciences Nv stocks?
plus_minus_icon
What is today’s traded volume of Atai Life Sciences Nv?
plus_minus_icon
What is today’s market capitalisation of Atai Life Sciences Nv?
plus_minus_icon
What is the 52-Week High and Low Range of Atai Life Sciences Nv?
plus_minus_icon
What percentage is Atai Life Sciences Nv down from its 52-Week High?
plus_minus_icon
What percentage is Atai Life Sciences Nv up from its 52-Week Low?
plus_minus_icon
Current Price
$1.4
$0.06
(4.48%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00